Brief: Theranexus, BBDF Sign Worldwide Exclusive License For BBDF-101

Thx Pharma SA

12/12/2019 17:40

Dec 12 (Reuters) - Theranexus SA  ALTHX.PA :
    * THERANEXUS AND BBDF FOUNDATION ANNOUNCE EXCLUSIVE
WORLDWIDE
LICENSING AGREEMENT FOR DRUG CANDIDATE BBDF-101 IN BATTEN'S
DISEASE
    * AGREEMENT PROVIDES FOR THE DEVELOPMENT AND
COMMERCIALIZATION OF
THE DRUG AFTER A UNIQUE CLINICAL STUDY THAT WILL BEGIN IN 2020

Source text: https://bit.ly/34bAEEp
Further company coverage:  ALTHX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))